News Releases | Olink Holding AB

Date	Title
Dec 01, 2021	Olink® Explore 3072 high-throughput proteomics platform now available: Significantly expands Olink's protein library for biomarker discovery
Nov 29, 2021	Melissa Amrein, at the University Hospital of Basel, Switzerland, is awarded the 2021 Novelties in Biomarkers prize at the Biomarkers of the Future Conference in Paris, France
Nov 23, 2021	Olink® Signature Q100 now available: A user friendly desktop instrument to broaden access to Olink’s multiplex protein analysis platform
Nov 11, 2021	Psomagen, Inc. is partnering with Olink Proteomics, enabling unprecedented multi-omics clinical studies
Nov 10, 2021	Olink reports third quarter 2021 financial results
Nov 05, 2021	Olink announces participation in November investor events
Nov 04, 2021	Fulgent Genetics offers multi-omic solutions to Pharma through addition of Olink proteomics platform
Oct 20, 2021	Olink to report third quarter 2021 financial results on November 10, 2021
Sep 01, 2021	Olink to present at two upcoming investor conferences
Aug 31, 2021	CellCarta expands its biomarker capabilities for clinical trials by adding Olink technology to its global services
Aug 11, 2021	Olink reports second quarter 2021 financial results
Jul 27, 2021	Olink: CORAL to use the Olink Proteomics platform to identify novel protein biomarkers and biological mechanisms for neurological diseases
Jul 21, 2021	UK Biobank-PPP expands proteomics study of 53,000 participants to Olink Explore 3072
Jul 14, 2021	Olink Holding AB (publ) Announces Pricing of Public Offering of American Depositary Shares by Selling Shareholders
Jul 13, 2021	Olink enters into an agreement with deCODE genetics for early access to the Olink Explore 3072 Platform
Jul 12, 2021	Olink announces preliminary financial results for the second quarter 2021
Jul 12, 2021	Olink Holding AB (publ) Launches Public Offering of American Depositary Shares by Selling Shareholders
Jun 23, 2021	Olink announces the new Explore 3072 high throughput proteomics platform, offering uncompromised data quality with coverage of all major biological pathways
Jun 15, 2021	Olink: SCALLOP launches clinical trial arm to uncover next level of drug target insights from proteomic profiling
Jun 02, 2021	Announcing Olink Signature Q100: facilitating access for researchers to Olink technology with a benchtop system dedicated to multiplex protein biomarker measurement